IMPORTANT NEW ADVANCE IN BREAST CANCER TREATMENT INTRAOPERATIVE RADIATION THERAPY The surgical management of breast cancer has undergone several very important revolutions over the past 20 years. When...
Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, according to randomized trial p
( American Society for Radiation Oncology ) Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years afte
Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, according to new research.
A 56-year-old Vietnam veteran man was admitted with a three-day history of worsening abdominal pain progressing into an acute abdomen. He had past medical history of Hepatitis C, diabetes mellitus, high blood pressure and chronic abdominal pain of unknown
Elderly patients are left 'languishing' on wards run by junior doctors rather than being moved to specialised units tended to by teams of consultants and nurses.